Long-term effects of modest weight loss in type II diabetic patients
- PMID: 3310940
Long-term effects of modest weight loss in type II diabetic patients
Abstract
Since most obese patients with type II diabetes are unable to achieve ideal body weight, this study examined whether more modest weight losses would provide a long-term benefit. Type II diabetic patients (N = 114) were treated in a behavioral weight control program and followed up for one year. Weight loss was significantly correlated with improvements in glycosylated hemoglobin values at posttreatment (r = .55) and one year (r = .51). Patients who lost more than 6.9 kg or had more than 5% reduction in body weight had significant improvements in glycosylated hemoglobin values at one year, while patients losing less weight had nonsignificant changes and those gaining weight had significant worsening. Thus, modest weight loss can have a long-term impact on glycemic control. However, the improvement in glycemic control for a given weight loss was greater initially than at one year, suggesting that energy restriction, in addition to weight loss, may contribute to initial improvement. Neither percent overweight nor diabetes treatment affected weight loss.
Similar articles
-
Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.Diabetes Metab. 2001 Dec;27(6):701-8. Diabetes Metab. 2001. PMID: 11852380
-
Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs.Int J Obes. 1990 Jun;14(6):495-503. Int J Obes. 1990. PMID: 2401586
-
Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis.Am J Med. 2004 Nov 15;117(10):762-74. doi: 10.1016/j.amjmed.2004.05.024. Am J Med. 2004. PMID: 15541326
-
Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.Diabete Metab. 1993 Jan-Feb;19(1):30-5. Diabete Metab. 1993. PMID: 8504882
-
Exogenous insulin therapy slows weight loss in type 2 diabetic patients.Int J Obes. 1988;12(2):149-55. Int J Obes. 1988. PMID: 3290132
Cited by
-
Traditional Atlantic Diet and Its Effect on Health and the Environment: A Secondary Analysis of the GALIAT Cluster Randomized Clinical Trial.JAMA Netw Open. 2024 Feb 5;7(2):e2354473. doi: 10.1001/jamanetworkopen.2023.54473. JAMA Netw Open. 2024. PMID: 38324314 Free PMC article. Clinical Trial.
-
The impact of leucine supplementation on body composition and glucose tolerance following energy restriction: an 8-week RCT in adults at risk of the metabolic syndrome.Eur J Clin Nutr. 2024 Feb;78(2):155-162. doi: 10.1038/s41430-023-01360-1. Epub 2023 Nov 3. Eur J Clin Nutr. 2024. PMID: 37923932 Free PMC article. Clinical Trial.
-
Management of hyperglycaemia in people with obesity.Clin Med (Lond). 2023 Jul;23(4):364-371. doi: 10.7861/clinmed.2023-0135. Clin Med (Lond). 2023. PMID: 37524409 Free PMC article.
-
Protocol for a randomized controlled trial comparing a very low-carbohydrate diet or moderate-carbohydrate plate-method diet for type 2 diabetes: the LEGEND (Lifestyle Education about Nutrition for Diabetes) trial.Trials. 2023 Jul 20;24(1):463. doi: 10.1186/s13063-023-07512-9. Trials. 2023. PMID: 37475033 Free PMC article.
-
Management of diabesity: Current concepts.World J Diabetes. 2023 Apr 15;14(4):396-411. doi: 10.4239/wjd.v14.i4.396. World J Diabetes. 2023. PMID: 37122433 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical